SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
1.250
0.00 (0.00%)
At close: Apr 23, 2025, 4:00 PM
1.290
+0.040 (3.20%)
Pre-market: Apr 24, 2025, 6:38 AM EDT
SeaStar Medical Holding Employees
SeaStar Medical Holding had 19 employees as of December 31, 2024. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$7,105
Profits / Employee
-$1,306,842
Market Cap
10.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19 | 7 | 58.33% |
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ICU News
- 16 days ago - FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery - GlobeNewsWire
- 27 days ago - SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 weeks ago - SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - GlobeNewsWire
- 5 weeks ago - NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award - PRNewsWire
- 2 months ago - SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewsWire
- 3 months ago - SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial - GlobeNewsWire
- 3 months ago - FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome - GlobeNewsWire
- 3 months ago - SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewsWire